Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (101-110 of 399) with videos related to

Pageof 40
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 14, 2019
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment ParadigmViswanathan Mohan, Mark E Cooper, David R Matthews, et al.
Advances in Chronic Kidney Disease|March 28, 2018
New Glucose-Lowering Agents for Diabetic Kidney DiseaseLisanne C de Vos, Thushan S Hettige, Mark E Cooper
Current Opinion in Nephrology and Hypertension|October 27, 2023
Novel pharmacological interventions for diabetic kidney diseaseSeng Kiong Tan, Jairo A Pinzon-Cortes, Mark E Cooper
The International Journal of Biochemistry & Cell Biology|January 22, 2008
Localization of the ezrin binding epitope for advanced glycation endproductsE Anne McRobert, Anjali Tikoo, Mark E Cooper, et al.
Advances in Chronic Kidney Disease|May 1, 2014
New insights into the use of biomarkers of diabetic nephropathyJay C Jha, Karin A M Jandeleit-Dahm, Mark E Cooper
Current Opinion in Nephrology and Hypertension|November 18, 2014
Nox-4 and progressive kidney diseaseVicki Thallas-Bonke, Karin A M Jandeleit-Dahm, Mark E Cooper
Diabetes Research and Clinical Practice|December 3, 2017
SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitusMichael d'Emden, John Amerena, Gary Deed, et al.
Kidney International|March 13, 2003
Dialysis delayed is death prevented: a clinical perspective on the RENAAL studyMerlin C Thomas, Mark E Cooper, Shahnaz Shahinfar, et al.
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
ACE2, a new regulator of the renin-angiotensin systemLouise M Burrell, Colin I Johnston, Christos Tikellis, et al.
Diabetes, Obesity & Metabolism|June 20, 2024
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?Fabrice Bonnet, Mark E Cooper, Laetitia Kopp, et al.
Pageof 40

Showing results (101-110 of 399) with videos related to

Sort By:
Pageof 40
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 14, 2019
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment ParadigmViswanathan Mohan, Mark E Cooper, David R Matthews, et al.
Advances in Chronic Kidney Disease|March 28, 2018
New Glucose-Lowering Agents for Diabetic Kidney DiseaseLisanne C de Vos, Thushan S Hettige, Mark E Cooper
Current Opinion in Nephrology and Hypertension|October 27, 2023
Novel pharmacological interventions for diabetic kidney diseaseSeng Kiong Tan, Jairo A Pinzon-Cortes, Mark E Cooper
The International Journal of Biochemistry & Cell Biology|January 22, 2008
Localization of the ezrin binding epitope for advanced glycation endproductsE Anne McRobert, Anjali Tikoo, Mark E Cooper, et al.
Advances in Chronic Kidney Disease|May 1, 2014
New insights into the use of biomarkers of diabetic nephropathyJay C Jha, Karin A M Jandeleit-Dahm, Mark E Cooper
Current Opinion in Nephrology and Hypertension|November 18, 2014
Nox-4 and progressive kidney diseaseVicki Thallas-Bonke, Karin A M Jandeleit-Dahm, Mark E Cooper
Diabetes Research and Clinical Practice|December 3, 2017
SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitusMichael d'Emden, John Amerena, Gary Deed, et al.
Kidney International|March 13, 2003
Dialysis delayed is death prevented: a clinical perspective on the RENAAL studyMerlin C Thomas, Mark E Cooper, Shahnaz Shahinfar, et al.
Trends in Endocrinology and Metabolism: TEM|April 28, 2004
ACE2, a new regulator of the renin-angiotensin systemLouise M Burrell, Colin I Johnston, Christos Tikellis, et al.
Diabetes, Obesity & Metabolism|June 20, 2024
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?Fabrice Bonnet, Mark E Cooper, Laetitia Kopp, et al.
Pageof 40